May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Intravitreal triamcinolone used intraoperatively during cataract surgery in patients with pre–existing diabetic macular oedema
Author Affiliations & Notes
  • D. Steel
    Ophthalmology, Sunderland Eye Infirmary, Sunderland, United Kingdom
  • M. Habib
    Ophthalmology, Sunderland Eye Infirmary, Sunderland, United Kingdom
  • Footnotes
    Commercial Relationships  D. Steel, None; M. Habib, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4157. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Steel, M. Habib; Intravitreal triamcinolone used intraoperatively during cataract surgery in patients with pre–existing diabetic macular oedema . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4157.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To assess the effect of intravitreal triamcinolone injection at the time of cataract surgery on the treatment, and the prevention of the exacerbation, of diabetic macular oedema Method: Longitudinal pilot study of 10 patients (16 eyes) undergoing cataract surgery with phacoemulsification and IOL. Patients either had persistent foveal oedema despite previous laser or foveal oedema with no adequate view to perform pre–operative laser. All patients had 4 mg of triamcinolone injected via the inferotemporal pars plana into the inferior vitreous cavity at the end of surgery Results: Pre–operative visual acuities ranged from 20/120 to HM. Eight patients ( 14 eyes) had clinically dry maculae at six weeks following surgery and all had a subjective improvement in visual acuity. There was an objective improvement in vision in 14 eyes with a median improvement of 3.4 lines. 50% of eyes achieved 20/40 vision or better which compares favourably with published studies of similar cases. Follow up ranged from 3–15 months with no deterioration in vision observed. There were no cases of endophthalmitis. Two cases developed transiently raised intraocular pressure which was controlled with topical medication. Post operative macular laser was applied in 7 eyes. Conclusion: These results are encouraging with an improvement in vision in most cases and no deterioration in macular oedema observed. The technique deserves further study.

Keywords: diabetic retinopathy • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×